Christina M. Corley Sells 4,000 Shares of CDW Corporation (NASDAQ:CDW) Stock

CDW Corporation (NASDAQ:CDW) insider Christina M. Corley sold 4,000 shares of the stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $62.40, for a total transaction of $249,600.00. Following the completion of the sale, the insider now directly owns 63,843 shares in the company, valued at $3,983,803.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

CDW Corporation (CDW) opened at 63.56 on Monday. The company has a 50 day moving average of $60.87 and a 200-day moving average of $57.51. The stock has a market capitalization of $9.98 billion, a P/E ratio of 25.86 and a beta of 1.08. CDW Corporation has a 52-week low of $40.56 and a 52-week high of $66.33.

CDW Corporation (NASDAQ:CDW) last posted its quarterly earnings results on Wednesday, May 3rd. The information technology services provider reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.04. The firm had revenue of $3.32 billion for the quarter, compared to analysts’ expectations of $3.24 billion. CDW Corporation had a net margin of 2.85% and a return on equity of 55.44%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.67 earnings per share. Equities research analysts anticipate that CDW Corporation will post $3.83 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Christina M. Corley Sells 4,000 Shares of CDW Corporation (NASDAQ:CDW) Stock” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/2722419/christina-m-corley-sells-4000-shares-of-cdw-corporation-nasdaqcdw-stock.html.

Hedge funds have recently bought and sold shares of the stock. Cambridge Investment Research Advisors Inc. raised its stake in CDW Corporation by 1.3% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,542 shares of the information technology services provider’s stock valued at $262,000 after buying an additional 58 shares during the last quarter. CENTRAL TRUST Co raised its stake in CDW Corporation by 1.1% in the first quarter. CENTRAL TRUST Co now owns 6,183 shares of the information technology services provider’s stock valued at $357,000 after buying an additional 65 shares during the last quarter. Raymond James Trust N.A. raised its stake in CDW Corporation by 1.4% in the first quarter. Raymond James Trust N.A. now owns 5,969 shares of the information technology services provider’s stock valued at $344,000 after buying an additional 83 shares during the last quarter. Atria Investments LLC raised its stake in CDW Corporation by 2.1% in the first quarter. Atria Investments LLC now owns 3,962 shares of the information technology services provider’s stock valued at $229,000 after buying an additional 83 shares during the last quarter. Finally, Utah Retirement Systems raised its stake in CDW Corporation by 0.3% in the first quarter. Utah Retirement Systems now owns 29,700 shares of the information technology services provider’s stock valued at $1,714,000 after buying an additional 100 shares during the last quarter. 90.91% of the stock is currently owned by hedge funds and other institutional investors.

A number of brokerages have commented on CDW. Zacks Investment Research raised shares of CDW Corporation from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a research report on Tuesday, July 11th. BidaskClub downgraded shares of CDW Corporation from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 29th. Royal Bank Of Canada increased their price objective on shares of CDW Corporation from $64.00 to $70.00 and gave the company an “outperform” rating in a research report on Monday, June 26th. Robert W. Baird reissued a “buy” rating on shares of CDW Corporation in a research report on Saturday, May 13th. Finally, Barclays PLC reissued an “overweight” rating and issued a $64.00 price objective (up from $62.00) on shares of CDW Corporation in a research report on Monday, May 1st. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. CDW Corporation has a consensus rating of “Buy” and an average target price of $62.28.

About CDW Corporation

CDW Corporation (CDW) is a provider of integrated information technology (IT) solutions in the United States, Canada and the United Kingdom. The Company’s segments include Corporate, Public and Other. The Corporate segment consists of private sector business customers in the United States based on employee size between Medium/Large customers, which primarily includes organizations with more than 100 employees, and Small Business customers, which primarily includes organizations with up to 100 employees.

Insider Buying and Selling by Quarter for CDW Corporation (NASDAQ:CDW)

Receive News & Ratings for CDW Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CDW Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


Leave a Reply

© 2006-2017 Ticker Report. Google+.